Effective immediately, this Advisory Notice supersedes CME Group Market Regulation Advisory Notice RA1711-5 from August 11, 2017. It is being issued based on the CFTC Division of Market Oversight’s no-action relief from certain position aggregation requirements under Commission Regulation 150.4 issued on July 31, 2019, pursuant to CFTC Letter No. 19-19.
Click HERE to view the full advisory.